HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer.

AbstractBACKGROUND:
The results of preliminary studies of photodynamic therapy (PDT) for palliation of patients with bile duct cancer with hematoporphyrin derivative have been good. Rapid elimination of a photosensitizer could potentially shorten the time requirement for shielding from light. This would enhance the benefit of this form of palliative treatment. Therefore the feasibility of PDT was investigated for nonresectable bile duct cancer by using 5-aminolevulinic acid.
METHODS:
Four patients with nonresectable bile duct cancer underwent cholangiography, cholangioscopy, and intraductal US before PDT. Light activation was performed 5 to 7 hours after oral administration of 5-aminolevulinic acid. All patients had an endoprosthesis placed in the bile duct after PDT.
RESULTS:
Cholangioscopy 72 hours after PDT revealed superficial fibrinoid necrosis. However, 4 weeks after PDT there was no significant reduction in bile duct stenoses. Two patients had infectious complications develop, but phototoxicity was not observed.
CONCLUSIONS:
Although superficial tumor necrosis was evident, PDT with 5-aminolevulinic acid failed to significantly reduce malignant bile duct obstruction. Therefore 5-aminolevulinic acid-PDT cannot be recommended for the palliative treatment of bile duct cancer.
AuthorsT Zoepf, R Jakobs, A Rosenbaum, D Apel, J C Arnold, J F Riemann
JournalGastrointestinal endoscopy (Gastrointest Endosc) Vol. 54 Issue 6 Pg. 763-6 (Dec 2001) ISSN: 0016-5107 [Print] United States
PMID11726858 (Publication Type: Journal Article)
Chemical References
  • Aminolevulinic Acid
Topics
  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Aminolevulinic Acid (administration & dosage)
  • Bile Duct Neoplasms (diagnosis, drug therapy)
  • Cholangiography
  • Cholangiopancreatography, Endoscopic Retrograde (methods)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Palliative Care (methods)
  • Photochemotherapy (methods)
  • Pilot Projects
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: